Congress Passes Spending Bill Continuing Protections for State Medical Marijuana Programs

The Justice Department will continue to be prohibited from interfering in state medical marijuana laws under the federal spending bill passed Thursday in the Senate. The bill has already passed the House, and President Trump has said he will sign it.

The legislation includes a provision that is intended to prevent the department, including the Drug Enforcement Administration, from using funds to arrest or prosecute patients, caregivers, and businesses that are acting in compliance with state medical marijuana laws.

The provision stems from…

Click Here to Continue Reading…


DEA asks Colorado AG’s office for info on marijuana crimes, “for the new administration”

Amid speculation about how the Trump administration will confront marijuana legalization in states such as Colorado, a Drug Enforcement Administration supervisor has sent an e-mail to a prosecutor in the state attorney general’s office seeking information, “for the new administration.”

The e-mail was sent early last month by a supervisor on the financial investigations team in the DEA’s Denver field office to Michael Melito, a senior assistant attorney general. The e-mail asks for…

CONTINUE READING: Click Here to Continue Reading Article …


Several Bills Filed in Congress to Create “Path to Marijuana Reform”

The United States Capitol in Washington, DC (Wikimedia/David Maiolo)

The Congressional Cannabis Caucus flexed its muscles Thursday as members of Congress filed a package of bills aimed at creating a “path to marijuana reform” at the federal level and protecting and preserving marijuana laws in states where it is legal.

Two Oregon politicians, Sen. Ron Wyden (D) and Rep. Earl Blumenauer (D) led the charge, announcing a bipartisan package of three bills, including a marijuana…

CONTINUE READING: Click Here to Continue Reading Article …


Joint Legislation: Federal Bills Would End Marijuana Prohibition in the United States

WASHINGTON, DC — Senator Ron Wyden and Representatives Earl Blumenauer and Jared Polis have introduced legislation in the House and Senate — to permit states to establish their own marijuana regulatory policies free from federal interference.

In addition to removing marijuana from the United States Controlled Substances Act, this legislation also removes enforcement power from the US Drug Enforcement Administration in matter concerning marijuana possession, production, and sales —…

CONTINUE READING: Click Here to Continue Reading Article …


DEA to Classify Liquid, Synthetic THC as a Schedule II Controlled Substance

WASHINGTON, DC — Officials from the US Drug Enforcement Administration (DEA) have recommended that Syndros, a liquid form of synthetic THC, be classified as a Schedule II controlled substance under federal law.

Food and Drug Administration (FDA) officials determined last year that the drug formulation is safe and effective for use by patients with cancer and AIDS.

Two other synthetic forms of THC, dronabinol and nabilone, are also FDA approved. Dronabinol (aka Marinol) is a…

CONTINUE READING: Click Here to Continue Reading Article …


Drug busts underway in Denver metro area are aimed at growers shipping weed out of state

Local authorities are busting members of a suspected ring that has been growing and distributing pot out-of-state, a Drug Enforcement Agency spokesman in the Denver office said Thursday morning.

The DEA is assisting in the raids, which are an outgrowth of an investigation by the 18th Judicial District.

All warrants are under seal, the DEA spokesman said. The organization has allegedly been growing and shipping marijuana out-of-state in violation of state and federal laws.

CONTINUE READING: Click Here to Continue Reading Article …


Marijuana in the age of Trump: An untenable conflict between feds, legalized states

Legal weed is at a crossroads.

While some cannabis legalization proponents claim their movement has grown too big to fail, it has also proved too significant for the federal government to ignore.

The Trump administration is mulling its approach to the state-regulated systems that conflict with federal law. On Capitol Hill, conversations about legal cannabis have picked up steam.

Amid a time of unknowns surrounding federal marijuana policy, one thing is certain: The status quo is no longer…

CONTINUE READING: Click Here to Continue Reading Article …


Memo to Congress: DEA Dumped the “Gateway-Theory” Due to Science

WASHINGTON, DC — Americans for Safe Access, a national nonprofit dedicated to ensuring safe and legal access to medical cannabis for therapeutic use and research, has sent a memo to Congress informing members that the Drug Enforcement Administration (DEA) has removed false information about cannabis from its website after months of public pressure. The memo explains:

Forty-four states now allow patients under their physician’s care to use medical…

CONTINUE READING: Click Here to Continue Reading Article …


Document on marijuana health risks no longer listed DEA website

A document that put the DEA under fire for disseminating misinformation about marijuana’s health effects has disappeared from the agency’s website.

As of Monday, “The Dangers and Consequences of Marijuana Abuse,” a nearly 45-page publication on the various ramifications of cannabis use, no longer was available on the U.S. Drug Enforcement Administration’s website.

The document last year was at the center of a legal petition by Americans for Safe Access claiming the DEA’s publishing of…

CONTINUE READING: Click Here to Continue Reading Article …


DEA Removes Marijuana Misinformation from Website After Months of Public, Legal Pressure

WASHINGTON, DC — After months of public pressure, the Drug Enforcement Administration (DEA) has removed factually inaccurate information from its website.

The change comes after Americans for Safe Access, a national nonprofit dedicated to ensuring safe and legal access to medical cannabis for therapeutic use and research, filed a legal request with the Department of Justice last year demanding that the DEA immediately update and remove factually inaccurate…

CONTINUE READING: Click Here to Continue Reading Article …


So We Have Attorney General Sessions. Whats Next For Marijuana?

U.S. Senator Jeff Sessions of Alabama speaking to supporters at an immigration policy speech hosted by Donald Trump at the Phoenix Convention Center in Phoenix, Arizona. (WikiMedia Commons/Gage Skidmore)

Despite historic opposition, members of the United States Senate voted 52 to 47 last week to approve the nomination of Alabama Sen. Jeff Sessions for US Attorney General.

While we are disappointed with this outcome, we are pleased that several members of Congress cited the…

CONTINUE READING: Click Here to Continue Reading Article …


What will be AG Jeff Sessions’ first move on marijuana?

A new lawman has come to town, and the marijuana industry could be in for major upheaval.

But just how much change Attorney General Jeff Sessions might impart — and how quickly he’ll address federal marijuana enforcement — remain the multibillion-dollar question.

“It’s not like you could see agents come into every storefront in the United States tomorrow and deal with this. That’s not a reality,” drug policy expert John Hudak said Wednesday.

But if Sessions rescinds the 2013…

CONTINUE READING: Click Here to Continue Reading Article …


Senate Votes to Confirm Jeff Sessions as US Attorney General

Sen. Jeff Sessions (R-AL) listens to a question during confirmation hearings on Tuesday, January 10, 2017.

WASHINGTON, DC — The U.S. Senate voted 52 to 47 Wednesday to confirm Senator Jeff Sessions (R-AL) as Attorney General. Most Republicans voted for him; most Democrats voted against him.

The vote comes after two months of organized opposition as hundreds of organizations expressed concerns about Sessions’s record and racially-charged statements he has made in the…

CONTINUE READING: Click Here to Continue Reading Article …


Senate Judiciary Votes to Advance ‘Drug-War Dinosaur’ Jeff Sessions as Attorney General

Sen. Jeff Sessions (R-AL) listens to a question during confirmation hearings on Tuesday, January 10, 2017.

WASHINGTON, DC — The Senate Judiciary Committee voted Wednesday to advance the nomination of Jeff Sessions for Attorney General of the United States. The vote was 11 to 9, with no Democrats supporting the nominee. The nomination will now go to the Senate floor for a full and final vote.

“Jeff Sessions is a disaster for drug policy and criminal justice reform,”…

CONTINUE READING: Click Here to Continue Reading Article …


Senate Judiciary Advances the Nomination of Marijuana Prohibitionist Jeff Sessions to be the Attorney General

WASHINGTON, DC — Unfortunately, but not unexpectedly, the Senate Judiciary Committee advanced the confirmation of Jeff Sessions to be the next US Attorney General on a party line vote of 11 to 9.

There a numerous groups in the criminal justice advocacy space, ranging from the NAACP to the ACLU who are opposed Senator Sessions becoming the nation’s top law enforcement officer for various reasons, ranging from his positions on voting rights, capital punishment, and…

CONTINUE READING: Click Here to Continue Reading Article …


Live in a legalized state? Here are 9 ways federal marijuana laws are limiting your rights

While he was celebrating the end of a massive year for his cannabis-focused company Terra Tech, Derek Peterson was also scrambling to cope with some bad news.

His Newport Beach business had raised close to $20 million in capital to produce and sell marijuana products across the country, tripled the number of people it employs and applauded as Californians voted to legalize recreational marijuana in 2016. But Peterson also learned that the company managing payroll and health benefits for…

CONTINUE READING: Click Here to Continue Reading Article …


AG Nominee Sessions Responds to Marijuana Questions from Senators

Sen. Jeff Sessions (R-AL) listens to a question during confirmation hearings on Tuesday, January 10, 2017.

Attorney General nominee Sen. Jeff Sessions (R-AL) has issued written responses to marijuana-related questions from several US Senators, but those answers still do not clarify the Trump Administration’s stance on marijuana legalization by states.

While on the campaign trail, President-elect Trump said that marijuana legalization was an issue for the states to…

CONTINUE READING: Click Here to Continue Reading Article …


DEA, El Paso County authorities serve warrants targeting illegal indoor marijuana grows

Federal agents teamed up with authorities in El Paso County on Monday morning to serve several warrants and make arrests in connection with an out-of-state organization suspected of illegally growing marijuana east of Colorado Springs.

Officials say the pot was being grown indoors in violation of Colorado and federal laws.

Jim Gothe, a spokesman for the Drug Enforcement Administration in Denver, said he could not provide details in the cases because they are under seal. He added that an…

CONTINUE READING: Click Here to Continue Reading Article …


100,000+ Demand DEA Stop Spreading Lies About Medical Marijuana

WASHINGTON, DC Over 100,000 people have signed an Americans for Safe Access petition on Change.org demanding that the Drug Enforcement Administration (DEA) stop disseminating false information about medical cannabis immediately and ensure that all of their future information on medical cannabis treatment reflect medically-accurate, up-to-date facts.

View and sign the petition here.

Last year, Americans for Safe Access (ASA), a national nonprofit organization…

CONTINUE READING: Click Here to Continue Reading Article…


Hemp industry members file legal challenge against DEA’s new marijuana extract rule

The hemp industry has taken the DEA to court in the wake of a controversial new rule on marijuana extracts.

Denver’s Hoban Law Group, representing the Hemp Industries Association, Centuria Natural Foods and RMH Holdings LLC, on Friday filed a judicial review action against the U.S. Drug Enforcement Administration, alleging the agency overstepped its bounds when enacting a rule establishing coding for marijuana derivatives such as cannabidiol (CBD) oil. The action, Hoban attorneys…

CONTINUE READING: Click Here to Continue Reading Article …


Jeff Sessions Confirmation Hearing Draws Mixed Reactions from Marijuana Organizations

During his confirmation hearing for the position of Attorney General Tuesday, Sen. Jeff Sessions (R-AL) avoided giving a straight answer on how he will handle states that have legalized marijuana, drawing a mixed reaction from organizations advocating for further marijuana law reform.

Erik Altieri, Executive Director of the NORML, the National Organization for the Reform of Marijuana Laws, says Session’s responses could be “leaving the door open” for…

CONTINUE READING: Click Here to Continue Reading Article …


Jeff Sessions Evades Firm Answer on State Marijuana Laws

Sen. Jeff Sessions (R-AL) listens to a question during confirmation hearings on Tuesday, January 10, 2017.

During his confirmation for the position of Attorney General, Senator Jeff Sessions failed to give a straight answer with regard to how the Justice Department should respond to states that have legalized marijuana for medical or recreational use.

The Alabama Senator was questioned by both Sens. Patrick Leahy (D-VT) and Mike Lee (R-UT) with respect to whether the principles of…

CONTINUE READING: Click Here to Continue Reading Article …


NORML Releases Open Letter to Vice President-Elect Mike Pence on Marijuana Policy

Indiana Governor Mike Pence addresses a news conference where he was introduced as the vice presidential running mate of Republican U.S. presidential candidate Donald Trump in New York City, U.S., July 16, 2016. REUTERS/Carlo Allegri

National NORML, Michigan NORML and dozens of other state and local chapters have released an open letter to Vice President-Elect Pence seeking clarity and common sense from the incoming administration regarding marijuana policy.

During the campaign,…

CONTINUE READING: Click Here to Continue Reading Article …


New DEA rule on marijuana extracts, CBD causes commotion in cannabis industry

A little three-page document published this week in the U.S. Federal Register sent some fairly big shock waves through the cannabis industry.

The U.S. Drug Enforcement Administration filed a final rule notice to establish a Controlled Substances Code Number for “marihuana extract,” and subsequently maintaining marijuana, hemp and their derivatives as Schedule I substances. According to the notice:

This code number will allow DEA and DEA-registered entities to track quantities of this…

CONTINUE READING: Click Here to Continue Reading Article …


Hearing Set for Jeff Sessions Attorney General Nomination

U.S. Senator Jeff Sessions of Alabama speaking to supporters at an immigration policy speech hosted by Donald Trump at the Phoenix Convention Center in Phoenix, Arizona. (WikiMedia Commons/Gage Skidmore)

It’s official, Senate Judiciary Committee Chairman Chuck Grassley has set January 10-11, 2017 for the confirmation hearing of noted marijuana law reform opponent Senator Jeff Sessions (R-AL) to become the next Attorney General.

Already it appears that Sen. Grassley will…

CONTINUE READING: Click Here to Continue Reading Article …


Medical Marijuana Policy Roadmap: Solutions for State and Federal Law Conflicts

WASHINGTON, DC — Americans for Safe Access (ASA) on Thursday released a briefing book —“Medical Cannabis in America”— calling on Congress and the Obama Administration to end the conflict between federal and state governments on medical cannabis programs.

The report includes potential actions for President Obama to take during the lame duck session along with steps for the incoming Congress and President-elect Donald Trump.

ASA argues these suggestions would…

CONTINUE READING: Click Here to Continue Reading Article…


New Petition Demands DEA Correct Misinformation About Cannabis

WASHINGTON, DC — Americans for Safe Access, a national nonprofit dedicated to ensuring safe and legal access to cannabis for therapeutic use and research, filed a petition with the Department of Justice (DOJ) today demanding that the Drug Enforcement Administration (DEA) immediately update misinformation about cannabis.

The petition is being filed under the rules of the Information Quality Act (IQA, aka Data Quality Act), which requires administrative agencies to…

CONTINUE READING: Click Here to Continue Reading Article …


Trump Adds Another Marijuana Opponent to Cabinet

Rep. Tom Price (R-GA) has been picked by President-elect Donald Trump as Health and Human Services secretary.  (photo/Gage Skidmore)

Rep. Tom Price (R-GA) has been picked by President-elect Donald Trump as Health and Human Services secretary. (photo/Gage Skidmore)

President-elect Donald Trump has picked another marijuana opponent to join his cabinet, tabbing Georgia Rep. Tom Price to serve as  Health and Human Services secretary.

This could be bad news for state-sanctioned medical marijuana programs in the 28 states that allow it.  While the Department of Justice — which, if he is confirmed by the Senate,…

CONTINUE READING: Click Here to Continue Reading Article …


Lawmakers want to defund DEA’s marijuana eradication program

Christopher Ingraham, The Washington Post

In 2015, the Drug Enforcement Administration gave $20,000 to the state of New Hampshire to eradicate marijuana plants, according to federal documents. But the Granite State’s law enforcement agencies didn’t have much luck finding any weed to pull that year – their efforts uncovered a single outdoor grow site with a grand total of 27 plants.

Do the math, and U.S. taxpayers paid $740.74 for each pot plant uprooted in New Hampshire that…

CONTINUE READING: Click Here to Continue Reading Article …


Court: Budgetary Amendment Bars Federal Prosecution of State-Compliant Medical Marijuana Providers

Court: Budgetary Amendment Bars Federal Prosecution of State-Compliant Medical Marijuana Providers

SAN FRANCISCO, CA — Federal officials are not permitted to engage in the criminal prosecution of those who are engaged in activity related to medical marijuana absent evidence that the defendants are in clear violation of state law, according to a unanimous ruling by a three-judge panel on the Ninth Circuit Court of Appeals.

The ruling broadly interprets a 2014 federal budgetary amendment prohibiting the US Justice Department from spending any funds “to prevent … states … from implementing their own state laws that authorize the…

CONTINUE READING: Click Here to Continue Reading Article…


DEA Fails to Reschedule Marijuana, but Opens Path for More Research

The Drug Enforcement Administration (DEA) has decided that marijuana will remain classified as a Schedule I substance under the Controlled Substances Act. The decision to keep marijuana in the category reserved for drugs with no accepted medical uses and a high potential for abuse was, according to the DEA, based on consultation with the Department of Health and Human Services. According to DEA administrator Chuck Rosenberg, “If the scientific understanding about marijuana changes — and it could change — then the decision could…

Click Here to Continue Reading…


Federal Court of Appeals Upholds Ban on Prosecuting State-Compliant Medical Marijuana Businesses

Federal Court of Appeals Upholds Ban on Prosecuting State-Compliant Medical Marijuana Businesses

SAN FRANCISCO, CA — A three-judge panel of the US Court of Appeals for the 9th Circuit, covering nine western states, earlier this week ruled unanimously that the Department of Justice is barred by federal law from prosecuting medical marijuana businesses if those businesses are operating in compliance with state law.

This decision came in an appeal in which the court had consolidated ten different cases from California and Washington, in which the defendants — growers and dispensaries — had argued that their federal indictments should…

CONTINUE READING: Click Here to Continue Reading Article…


Appeals Court: DOJ Can’t Prosecute State-Legal MJ Businesses

In a big win for licensed marijuana companies, a federal appeals court in California ruled Tuesday that the U.S. Department of Justice can’t spend money to prosecute cannabis businesses that comply with state laws.

The 9th U.S. Circuit Court of Appeals in San Francisco ruled that the DOJ must comply with the Rohrabacher-Farr Amendment, which Congress first adopted in December 2014. It prohibits the DOJ from spending federal funds to interfere with the implementation of state marijuana laws.

The case wound up before the court, which covers…

CONTINUE READING: Click Here to Continue Reading Article …


Feds eradicate 5-acre illegal marijuana grow west of Colorado Springs, find 18,300 plants

Marijuana plants
Marijuana plants

Federal authorities eradicated 18,300 marijuana plants Thursday from an illegal grow operation spanning across about five acres of land in the Pike National Forest west of Colorado Springs.

The U.S. Forest Service says it also seized 2,000 pounds of marijuana growing infrastructure as part of the operation, which centered at a scene about six miles outside of Woodland Park, though an exact location was not provided.

The materials found included irrigation pipe, camping…

CONTINUE READING: Click Here to Continue Reading Article …


DEA: Marijuana Seizures Decline In 2015

DEA: Marijuana Seizures Decline In 2015

WASHINGTON, DC — Seizures of indoor and outdoor cannabis crops by the US Drug Enforcement Administration (DEA) fell in 2015, according to annual data compiled by the US Drug Enforcement Administration.

According to the DEA’s Domestic Cannabis Eradication/Suppression Statistical Report, agents eradicated 4.25 million marijuana plants nationwide in 2015. That total is slightly less than the total reported by the agency for the year 2014 (4.3 million) and continues to the ongoing decline in eradication totals since 2010, when the agency

CONTINUE READING: Click Here to Continue Reading Article …


When will the DEA announce its marijuana rescheduling decision?

The Drug Enforcement Administration flaked on its self-imposed deadline to announce whether to reschedule marijuana, and now it’s not clear when a decision might come.

In April, the DEA told lawmakers in a letter that it was reviewing information on rescheduling and “hopes to release its determination in the first half of 2016.” That hope ended when June did, and a DEA spokesman in Washington, D.C., told The Denver Post late last week that there is no update on the…

CONTINUE READING: Click Here to Continue Reading Article …


Leading California Medical Marijuana Oil Maker Busted

Leading California Medical Marijuana Oil Maker Busted

SANTA ROSA, CA — Police, including DEA agents, raided five properties associated with a well-known medical marijuana products manufacturer in Northern California’s Sonoma County Wednesday morning, detaining at least nine people and arresting one on suspicion of felony drug manufacture for his role in cannabis oil production.

Although medical marijuana has been legal in the state since voters approved it two decades ago, it was only last year that the legislature moved to bring state-wide regulation to the rapidly growing industry, and…

CONTINUE READING: Click Here to Continue Reading Article…


State Department: International Treaties Do Not Demand Monopoly on Marijuana Production

State Department: International Treaties Do Not Demand Monopoly on Marijuana Production

WASHINGTON, DC — United States treaty obligations do not mandate the federal government to limit marijuana production to a single licensed facility, according to written statements provided by the State Department to Sen. Kirsten Gillibrand (D-NY).

The Department’s statements run counter to opinions expressed by the US Drug Enforcement Administration (DEA), which has long alleged that there can only be one federally licensed cultivator of marijuana for research purposes – the University of Mississippi, as overseen by the US National…

CONTINUE READING: Click Here to Continue Reading Article …


State Department: NIDA Monopoly on Marijuana Research Unnecessary

State Department: NIDA Monopoly on Marijuana Research Unnecessary

WASHINGTON, DC — The Bureau of International Narcotics and Law Enforcement at the State Department has gone on record stating that the United States could issue multiple licenses for the cultivation of cannabis for medical and scientific purposes without violating the United Nations Single Convention on Narcotic Drugs treaty.

The statement came in response to a direct request from Senator Kirsten Gillibrand (D-NY) regarding whether issuing multiple licenses to grow medical marijuana was a violation of the Single Convention.

The State…

CONTINUE READING: Click Here to Continue Reading Article…


DEA Approves Study on Treating PTSD With Marijuana

On Thursday, the Multidisciplinary Association for Psychedelic Studies (MAPS) announced in a press release that they had received approval to study the effects of marijuana on treating PTSD in veterans.q4g89gcyl385qpt0vmeo

The U.S. Drug Enforcement Administration (DEA) has formally approved the first-ever randomized controlled trial of whole plant medical marijuana (cannabis) as a treatment for posttraumatic stress disorder (PTSD) in U.S. veterans. The DEA’s approval marks the first time a clinical trial intended to develop smoked…

Click Here to Continue Reading…


DEA Set to Act Imminently on Marijuana Rescheduling Petition

DEA Set to Act Imminently on Marijuana Rescheduling Petition

WASHINGTON, DC — The US Drug Enforcement Administration is prepared to respond in the coming months to an administrative petition calling for the reclassification of marijuana as a schedule I prohibited substance.

Replying to a July 2015 inquiry by US Sen. Elizabeth Warren (D-MA) and seven other senators, representatives from the DEA acknowledged that they intend to respond to a five-year-old rescheduling petition, filed by then Governors Christine Gregoire of Washington and Lincoln Chafee of Rhode Island, by this July.

The petition,

CONTINUE READING: Click Here to Continue Reading Article…


It Is Time to Deschedule, Not Reschedule, Cannabis

It Is Time to Deschedule, Not Reschedule, Cannabis

Under the US Controlled Substances Act of 1970, the cannabis plant and its organic cannabinoids are classified as schedule I prohibited substances — the most restrictive category available under the law.

A recent memorandum from the US Drug Enforcement Administration to several United States Senators indicates that the agency is prepared to respond in the coming months to a five-year-old petition seeking to amend the plant’s status as a schedule I prohibited substance.

Under the US Controlled Substances Act of 1970, the cannabis plant and…

CONTINUE READING: Click Here to Continue Reading Article…


DEA Eases Some Requirements for Clinical Trials on Cannabidiol

DEA Eases Some Requirements for Clinical Trials on Cannabidiol

WASHINGTON, DC — The Drug Enforcement Administration (DEA) says they are easing some of the requirements imposed by the Controlled Substances Act for researchers conducting clinical trials on cannabidiol (CBD), an extract of marijuana that has been used to reduce seizures in children, among other ailments.

According to a press release issued Wednesday by the DEA, the changes “will streamline the research process regarding CBD’s possible medicinal value and help foster ongoing scientific studies.”

Researchers who are conducting Food…

CONTINUE READING: Click Here to Continue Reading Article…


US Senators Seek More Information About Federal Efforts to Facilitate Medical Marijuana Research

US Senators Seek More Information About Federal Efforts to Facilitate Medical Marijuana Research

Follow-up letter comes after federal agency response leaves unanswered questions about efforts to address regulatory barriers to critical research

WASHINGTON, DC — United States Senators Elizabeth Warren (D-MA), Barbara Mikulski (D-MD), Barbara Boxer (D-CA), Ron Wyden (D-OR), Jeff Merkley (D-OR), Kirsten Gillibrand (D-NY), Edward J. Markey (D-MA), and Cory Booker (D-NJ) sent a follow-up letter to the U.S. Department of Health and Human Services (HHS), the Office of National Drug Control Policy (ONDCP), and the Drug Enforcement…

CONTINUE READING: Click Here to Continue Reading Article …


Congress Adopts Significant Drug Policy Reforms in New Spending Bill

Congress Adopts Significant Drug Policy Reforms in New Spending Bill

WASHINGTON, DC — Congress approved a must-pass spending bill this week that includes language that stops the Obama Administration’s Department of Justice from spending money to block the implementation of state medical marijuana laws. The amendment was passed last year on a temporary basis and must be renewed this year.

“The renewal of this amendment should bring relief for medical marijuana patients and business owners,” said Michael Collins, Deputy Director of National Affairs for the Drug Policy Alliance. “For decades Congress…

CONTINUE READING: Click Here to Continue Reading Article…


Ban on Justice Deptartment Interference in State Medical Marijuana Laws to Continue

Ban on Justice Deptartment Interference in State Medical Marijuana Laws to Continue

Justice Department Will Continue to Be Prohibited From Interfering in State Medical Marijuana Laws Under New Spending Bill

The appropriations bill unveiled late Tuesday in Congress includes the Rohrabacher-Farr Amendment, which is intended to prevent the DOJ and DEA from arresting or prosecuting patients, caregivers, and businesses that are acting in compliance with state medical marijuana laws; the spending plan also renews the Harris Amendment, which prevents the District of Columbia from regulating marijuana for adult use

WASHINGTON, D.C….

CONTINUE READING: Click Here to Continue Reading Article …


Congress Unveils 2016 Omnibus Spending Bill, Reauthorizes Marijuana Protections

Congress Unveils 2016 Omnibus Spending Bill, Reauthorizes Marijuana Protections

WASHINGTON, DC — Members of Congress on Wednesday unveiled the 2016 Omnibus Appropriations bill, legislation that is responsible for funding the federal government through the 2016 fiscal year.  

While stand alone marijuana related bills rarely gain traction in Congress, the annual omnibus appropriations bill has become a tool for federal lawmakers to pass marijuana related language into annual spending guidelines.

In last week’s Legislative Round Up, we covered five distinct marijuana provisions that lawmakers sought to include in the…

CONTINUE READING: Click Here to Continue Reading Article …


Mounting Pressure on DEA Head to Resign for Calling Medical Marijuana “A Joke”

ARLINGTON, VA — Medical marijuana patients and supporters gathered Friday at DEA headquarters in Arlington, Virginia, to hand in more than 100,000 petition signatures demanding the resignation or firing of DEA Administrator Chuck Rosenberg after he called medical marijuana “a joke.”

The petition, which was started only two weeks ago, has more than doubled the number of signatures on an earlier petition that helped prompt the ouster of Rosenberg’s predecessor, former DEA head Michele Leonhart.

After walking from the nearby site of…

CONTINUE READING: Click Here to Continue Reading Article …


DEA Chief Shows Yet Again He Has No Clue About Marijuana

DEA Chief Shows Yet Again He Has No Clue About Marijuana

DEA Chief Administrator Chuck Rosenberg has once again managed to stick his foot in his mouth about cannabis. Earlier this week, Rosenberg stated that the notion of patients finding therapeutic relief from cannabis bothered him, going on to say “don’t call it medicine — that is a joke.”

The statement comes just a couple of months after the newly appointed DEA chief admitted that he was “not an expert” on marijuana, and had difficulty stating with certainty whether marijuana was more or less dangerous than heroin. After a week…

CONTINUE READING: Click Here to Continue Reading Article …


DEA Chief Rosenberg : Marijuana as Medicine is “A Joke”

DEA Chief Rosenberg : Marijuana as Medicine is “A Joke”

WASHINGTON, DC — Herbal cannabis is not medicinal and should not be classified as such, according to public statements made recently by US Drug Enforcement Administration Director Chuck Rosenberg.

Speaking to reporters on Wednesday, Rosenberg acknowledged that constituents in the plant possess “great promise” as potential therapies. But he dismissed the notion of the plant itself as medicinal. “That is a joke,” he said.

Commenting on Rosenberg’s remark’s, NORML Deputy Director Paul Armentano said: “The DEA chief’s…

CONTINUE READING: Click Here to Continue Reading Article…